Navigation Links
Edison Pharmaceuticals, Inc. signs licensing agreement with Dainippon Sumitomo Pharma Co., Ltd. for development & commercialization of orphan mitochondrial and adult central nervous system disease drugs
Date:3/28/2013

MOUNTAIN VIEW, Calif., March 28, 2013 /PRNewswire/ -- Edison Pharmaceuticals today announced that it has entered into a research/development and commercialization agreement with Dainippon Sumitomo Pharma Co., Ltd. (DSP) for the development of EPI-743 and EPI-589 in Japan. Under the terms of the agreement, DSP will gain development and commercialization rights in Japan in exchange for Edison receiving $35 million in upfront and $15 million in R&D support. In addition, Edison will be eligible to receive $10-35 million in development milestones per indication and up to $460M in commercial milestone payments as well as royalties on commercial sales.

The initial scope of the transaction includes both pediatric orphan inherited mitochondrial and adult central nervous system diseases. Under the terms of the agreement, DSP will undertake activities required for development, approval, and commercialization of EPI-743 in Japan. The work will initially focus on orphan pediatric mitochondrial disease. Edison will retain 100% ownership and direct all research, clinical, and commercial development of EPI-743 and EPI-589 outside of Japan.

In addition, the parties will collaborate on the research and development of EPI-589 with a focus on adult central nervous system disease. This collaboration is based upon the emerging body of data implicating redox and mitochondrial dysfunction as a root cause of neurologic disorders.

Edison's translational platform is based on redox biochemistry.  It bridges key learnings derived from genetically confirmed pediatric rare mitochondrial disease to adult central nervous system disorders where redox and mitochondrial dysfunction are likely to also play a cr
'/>"/>

SOURCE Edison Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Edison Pharmaceuticals & Bambino Gesu Childrens Hospital Announce Initiation of EPI-743 Phase 2 Cobalamin C Deficiency Syndrome Clinical Trial
2. Samsung Medison Showcases New Medical Equipment and Technology with Samsung Electronics at RSNA 2012
3. Edison Pharmaceuticals Closes $20M Series F Financing
4. Edison Pharmaceuticals Announces Initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
5. Massive Hiring Event for Life Science Professionals in Edison, NJ on 9/18/12
6. Edison Pharmaceuticals Announces Positive Results of EPI-743 Phase 2A Leigh Syndrome Clinical Trial
7. EMA Grants Orphan Designation to Edison Pharmaceuticals for EPI-743 for Treatment of Leigh Syndrome
8. Carolinas HealthCare System and Edison Nation Collaborate to Drive Medical Innovation and Technology
9. Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product
10. Harwood Feffer LLP Announces Investigation of Spectrum Pharmaceuticals, Inc.
11. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Spectrum Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , Nov. 25, 2014 Halozyme Therapeutics, Inc. (NASDAQ: ... Jaffray Healthcare Conference in New York ... PDT . Dr. Helen Torley , President and ... The presentation will be webcast through the "Investors" section of ... will be made available for 90 days following the event. ...
(Date:11/24/2014)... 2014  CryoLife, Inc. (NYSE: CRY ), a ... and vascular surgery, announced today that it will participate in ... on Wednesday, December 3, 2014 at The New York Palace ... A live webcast of the Company,s presentation is scheduled ... overview of the company by Pat Mackin , President ...
(Date:11/24/2014)... MONTREAL , Nov. 24, 2014 /PRNewswire/ - Milestone ... clinical trial conducted in Melbourne, Australia ... antagonist for the potential treatment of paroxysmal supraventricular ... formulation of MSP-2017 was well tolerated at single ... an excellent safety profile, desirable PK properties including ...
Breaking Medicine Technology:Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference 2CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference 3Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 2Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 3
... , , ... (Nasdaq: IPCM ), a leading national hospitalist physician group practice ... was named by ACP Hospitalist as one of the ... the November 2009 issue of the magazine. , Dr. Vaidyan has ...
... VIEW, Calif., Nov. 24 Satellite Healthcare, one of the ... a major sponsor of nephrology research, today announced its full ... his effort to support the San Jose homeless this Thanksgiving ... chef for the past 20 years. But Nasrallah,s life was ...
Cached Medicine Technology:IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 2IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 3Satellite Healthcare and Renal Disease Survivor Elias Nasrallah Join Forces to Support the Homeless This Holiday Season 2
(Date:11/26/2014)... Sonoran Vein and Endovascular nurse, ... Distinguished Preceptorship Award from The American Association ... the advancement of nurse practitioners. The Distinguished Preceptorship ... had made a significant contribution toward increasing the ... of Nurse Practitioners (AANP) is the largest full-service ...
(Date:11/26/2014)... Vultures have developed highly specialized ways of dealing with ... researchers report. The new research investigated the different ... the guts of 50 turkey vultures and black vultures ... the vultures had more than 500 different types of ... found. The findings suggest that a vulture,s digestive ...
(Date:11/26/2014)... to peanut protein in household dust may increase the ... condition eczema, a new study reveals. About 2 ... allergic to peanuts. And severe eczema in infants has ... researchers noted. The new study included 359 infants ... the amount of peanut protein the children were exposed ...
(Date:11/26/2014)... News) -- Parents need to take an active role ... warns. Parents must make sure sports-playing teens have ... Dodick, chair of the American Migraine Foundation and a ... Medicine in Scottsdale, Ariz. in an American Migraine Foundation, ... coach involved with teens sports needs to have appropriate ...
(Date:11/24/2014)... 24, 2014 The Healthy Skin Care ... of affordable skin care products, recently announced its launch. ... readers a wide variety of articles, tips, and evaluations ... organic skincare alternatives. , According to Emily Lataille, the ... content includes thoroughly researched reviews, tips for the skin, ...
Breaking Medicine News(10 mins):Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:Infants With Eczema May Be More Prone to Peanut Allergy: Study 2Health News:Parents Need to Take Lead on Teen Concussion Prevention 2Health News:Skin Care Advice Blog The Healthy Skin Care Journal Now Accessible to the Public 2
... , BETHESDA, Md., Nov. 16 GetWellNetwork, Inc. ... chief operating officer. Ms. Perry, an experienced high-tech leader and ... level of growth and deliver on the promise of improving ... Among her priorities, Ms. Perry will focus on GetWellNetwork,s leadership ...
... extended-release niacin, or Niaspan , SUNDAY, Nov. 15 (HealthDay ... ezetimibe (Zetia), a drug used by millions of Americans ... cholesterol. , The trial, known as ARBITER-6 HALTS, was ... LDL-cholesterol-lowering Zetia was less effective than extended-release niacin (Niaspan), ...
... 16 Blue Water Spa, a Raleigh NC Day Spa and ... party and Raleigh food drive. Guests who donate frozen turkeys or ... receive a $10,000 spa gift certificate for luxury spa services. , ... on hand Wed. November 18 and Saturday December 12 to accept ...
... YORK, Nov. 16 Nearly every household has some sort of ... like. But how many people plan ahead for dental emergencies? ... leading provider of oral care products, although one in six Americans ... not prepared to deal with the problem. , "You keep ...
... ... researchers with online cognitive rehab tools for cognitive impairments caused by Alzheimer,s disease, Traumatic ... ... HAPPYneuron PRO, a suite of online cognitive rehab tools for a variety ...
... ... Socks for Kids who Wear Ankle-Foot Orthoses (AFOs) , ... Westchester, NY (PRWEB) November 16, 2009 -- Ross Daniel Adaptive ... marketplace debut and the launch of “Cool Clothes for Toes,” the first creatively styled sock ...
Cached Medicine News:Health News:GetWellNetwork Taps High-Tech Veteran Michele Perry as Chief Operating Officer 2Health News:Study Raises New Questions About Cholesterol Drug Zetia 2Health News:Study Raises New Questions About Cholesterol Drug Zetia 3Health News:Raleigh Day Spa, Blue Water Spa, Raffles Off $10,000 in Day Spa Packages for Contributing to Raleigh Food Drive 2Health News:Be Prepared for a Dental Emergency During the Holidays 2Health News:HAPPYneuron Launches Beta Program for Innovative Cognitive Rehab Tools at AMIA Conference in San Francisco 2Health News:HAPPYneuron Launches Beta Program for Innovative Cognitive Rehab Tools at AMIA Conference in San Francisco 3Health News:Ross Daniel Adaptive Apparel Announces Company Debut and 'Cool Clothes for Toes' 2Health News:Ross Daniel Adaptive Apparel Announces Company Debut and 'Cool Clothes for Toes' 3
The PowerLab/4ST is a high-performance recording unit with built-in amplifiers and is suitable for physiology teaching. It has been designed to cover the broad experimental requirements in life scien...
... The PowerLab/4SP is a high-performance data acquisition ... research applications including human and animal physiology, ... engineering. The unit is capable of recording ... (up to 200 000 samples per second ...
Worth 4-Dot Flashlight/Plastic for testing and training of visual functions and testing for fusion, suppression and/or diplopia. Red/green goggle included. Requires 2 C batteries (not included)....
They employ Lea Symbols. Contrast levels are the same at 25%, 10%, 5%, 2.5% and 1.25%. Each offers a different set of Lea Symbols to guard against memorization. Also uses recording forms (P/N 215400)...
Medicine Products: